Effects of Shoe Longitudinal Bending Stiffness

NCT ID: NCT04895501

Last Updated: 2022-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-07

Study Completion Date

2022-06-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Carbon plates inserted in competitive running shoes have been increasingly used in the past 2-3 years and several investigations have shown that these plates increase the longitudinal bending stiffness (LBS) of the shoe. It leads to a redistribution of muscle work and to a modification of the force generation conditions, which may reduce the energy cost of running (Cr) and improve performance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Only one study has investigated the effects of LBS in running bouts longer than 8 minutes but on the biomechanics part, and their effects on neuromuscular fatigue and prolonged running performance. The aim of this study is to compare shoes with and without carbon plates during a prolonged (21 km) running exercise on Cr, plantar flexor neuromuscular fatigue and running kinetics and kinematics to estimate the changes high-LBS may induce on fatigue and subsequent performance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Runners

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

running with stiff shoes

21 km of running with stiff shoes followed by a time-to-exhaustion run.

Group Type ACTIVE_COMPARATOR

running flexible shoes

Intervention Type OTHER

21kms of running flexible shoes followed by a time-to-exhaustion run.

running flexible shoes

21 km of running flexible shoes followed by a time-to-exhaustion run.

Group Type EXPERIMENTAL

running flexible shoes

Intervention Type OTHER

21kms of running flexible shoes followed by a time-to-exhaustion run.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

running flexible shoes

21kms of running flexible shoes followed by a time-to-exhaustion run.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged ≥ 18 and ≤ 50 years.
* men
* experienced, well-trained endurance runners with the capacity to run 21km in less than 1h 40 and who train more than 5h a week.
* free from muscular, bone or joint injuries
* free from neurologic disease
* approval received from a physician

Exclusion Criteria

* currently participating in a structured exercise program
* injury in the 3 months prior to the protocol
* chronic joint pathologies (e.g.: repetitive sprains, patellar or ligament problems)
* the intake of corticosteroids within 3 months (inhalation, infiltration or history of prolonged corticosteroid therapy).
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Léonard FEASSON, Phd

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unités de Myologie et de Médecine du Sport

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00726-35

Identifier Type: OTHER

Identifier Source: secondary_id

21CH034

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Orthotics and Running
NCT04901442 UNKNOWN NA